Neumora Therapeutics Inc's Customers Performance

Name: Neumora Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

NMRA

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


NMRA's Source of Revenues		• List of NMRA Customers

for the same period Neumora Therapeutics Inc

• List of NMRA Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Neumora Therapeutics Inc's Comment on Sales, Marketing and Customers

The company addresses regulatory requirements and compliance associated with marketing authorization, clinical trials, and product approval processes in the United States and international markets, including the European Union.

News about Neumora Therapeutics Inc Contracts

Neumora Therapeutics Advances Brain Disease Programs with Exciting Initiatives and Promising Drug Candidates

Neumora Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative treatments for brain diseases, has recently made significant progress in its mission. The company announced the initiation of a Phase 1b study for NMRA-511, a potential breakthrough treatment for Alzheimer s disease agitation. Additionally, the company revealed the clearance of NMRA-266 s Investigational New Drug Application (IND), marking the initiation of a Phase 1 clinical study for this drug, targeting schizophrenia treatment. These achievements underscore Neumora Therapeutics commitment to addressing pressing medical challenges and improving patient outcomes.NMRA-511 for Alzheimer s Disease Agitation:NMRA-...

Neumora Therapeutics Inc’s Comment on Sales, Marketing and Customers

NMRA's Stock Performance relative to it's Customers

NMRA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Neumora Therapeutics Inc	143.17	0.00	-222.39	96
SUBTOTAL	0.00	0.00	0.00	-

Sources: Neumora Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Neumora Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Neumora Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.